宫颈癌与COVID:疫情初期影响评估及英格兰女性后续影响预测的队列研究
这项回顾性对照队列研究收集了英格兰北部6个癌症中心2019年5–10月(疫情前队列)和2020年5–10月(COVID队列)所有宫颈癌诊断数据,共406例(2019年233例,2020年173例),绝对诊断数减少25.7%(n=60),主要因低分期病例减少(2019年104例降至2020年77例)。将数据与疫情期间筛查暂停相关的额外病例结合进行预测,提示未来3年英格兰将分别新增局部、区域和远处病变586例、228例和105例;预测工具提示每中心每月增加2或3例手术容量可分别在12个月和7个月内消除超额病例。
要点
- 2020年5–10月宫颈癌诊断数较2019年同期减少25.7%(n=60),低分期病例从104例降至77例。
- 预测未来3年英格兰将新增局部、区域和远处病变病例分别为586例、228例和105例。
- 每中心每月增加2或3例手术容量可分别在12个月和7个月内消除超额病例。
核心结论
- 未来3年宫颈癌病例可能显著增加,增加手术容量或可减轻这一影响且不增加并发症或死亡率。
研究设计与样本
- 回顾性收集2019年5–10月(疫情前队列)和2020年5–10月(COVID队列)所有宫颈癌诊断数据,排除复发患者。
- 共登记406例患者,2019年233例,2020年173例。
主要发现
- 宫颈癌绝对诊断数减少25.7%(n=60),主要因低分期病例减少(2019年104例降至2020年77例)。
- 预测未来3年英格兰将新增局部病变586例、区域病变228例、远处病变105例。
- 每中心每月增加2例手术容量可在12个月内消除超额病例,增加3例可在7个月内消除。
临床怎么用
- 作者认为未来3年宫颈癌病例可能显著增加,增加手术容量或可减轻影响且不增加并发症或死亡率。
- 预测工具提示每中心每月增加2或3例手术容量可分别在12个月和7个月内消除超额病例。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review the effect of the COVID-19 pandemic on the diagnosis of cervical cancer and model the impact on workload over the next 3 years. DESIGN: A retrospective, control, cohort study. SETTING: Six cancer centres in the North of England representing a combined population of 11.5 million. METHODS: Data were collected retrospectively for all diagnoses of cervical cancer during May-October 2019 (Pre-COVID cohort) and May-October 2020 (COVID cohort). Data were used to generate tools to forecast case numbers for the next 3 years. MAIN OUTCOME MEASURES: Histology, stage, presentation, onset of symptoms, investigation and type of treatment. Patients with recurrent disease were excluded. RESULTS: 406 patients were registered across the study periods; 233 in 2019 and 173 in 2020, representing a 25.7% (n = 60) reduction in absolute numbers of diagnoses. This was accounted for by a reduction in the number of low stage cases (104 in 2019 to 77 in 2020). Adding these data to the additional cases associated with a temporary cessation in screening during the pandemic allowed development of forecasts, suggesting that over the next 3 years there would be 586, 228 and 105 extra cases of local, regional and distant disease, respectively, throughout England. Projection tools suggest that increasing surgical capacity by two or three cases per month per centre would eradicate this excess by 12 months and 7 months, respectively. CONCLUSIONS: There is likely to be a significant increase in cervical cancer cases presenting over the next 3 years. Increased surgical capacity could mitigate this with little increase in morbidity or mortality. TWEETABLE ABSTRACT: Covid will result in 919 extra cases of cervical cancer in England alone. Effects can be mitigated by increasing surgical capacity.
引用
- Davies JM, Spencer A, Macdonald S, et al. Cervical cancer and COVID-an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study. BJOG. 2022. PMID: 35015334. doi:10.1111/1471-0528.17098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。